Phillip S Blanchette

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 27, 2025
Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors-related AKI.

Phillip S Blanchette, Jennifer Reid, Lucie Richard

|Oct 02, 2019
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.

Phillip S Blanchette, Melody Lam, Lucie Richard

|Mar 10, 2018
Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.

P S Blanchette, D N Desautels, G R Pond

Pageof 1